State of Wisconsin Investment Board
KYMR icon

State of Wisconsin Investment Board’s Kymera Therapeutics KYMR Stock Holding History

State of Wisconsin Investment Board’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.1M Buy
37,185
+10,672
+40% +$845K 0.01% 1186
2025
Q4 		$2.06M Sell
26,513
-1,259
-5% -$85K ﹤0.01% 1402
2025
Q3 		$1.57M Sell
27,772
-5,000
-15% -$226K ﹤0.01% 1454
2025
Q2 		$1.43M Sell
32,772
-24,448
-43% -$842K ﹤0.01% 1441
2025
Q1 		$1.57M Buy
57,220
+11,632
+26% +$424K ﹤0.01% 1333
2024
Q4 		$1.83M Buy
45,588
+4,858
+12% +$219K ﹤0.01% 1316
2024
Q3 		$1.93M Sell
40,730
-25,707
-39% -$1.14M ﹤0.01% 1323
2024
Q2 		$1.98M Buy
66,437
+28,590
+76% +$990K 0.01% 1293
2024
Q1 		$1.52M Buy
37,847
+8,248
+28% +$295K ﹤0.01% 1316
2023
Q4 		$754K Sell
29,599
-9,024
-23% -$161K ﹤0.01% 1482
2023
Q3 		$537K Buy
38,623
+3,000
+8% +$60.3K ﹤0.01% 1721
2023
Q2 		$819K Buy
35,623
+2,704
+8% +$77.5K ﹤0.01% 1542
2023
Q1 		$975K Buy
32,919
+716
+2% +$23.1K ﹤0.01% 1487
2022
Q4 		$804K Sell
32,203
-2,068
-6% -$55.1K ﹤0.01% 1617
2022
Q3 		$746K Buy
34,271
+2,714
+9% +$71.5K ﹤0.01% 1712
2022
Q2 		$621K Sell
31,557
-14,443
-31% -$337K ﹤0.01% 1965
2022
Q1 		$1.95M Buy
46,000
+8,600
+23% +$363K ﹤0.01% 1506
2021
Q4 		$2.38M Hold
37,400
– – ﹤0.01% 1237
2021
Q3 		$2.2M Hold
37,400
– – ﹤0.01% 1261
2021
Q2 		$1.81M Buy
37,400
+23,800
+175% +$1.03M ﹤0.01% 1313
2021
Q1 		$528K Buy
+13,600
New +$819K ﹤0.01% 1582

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State of Wisconsin Investment Board's KYMR Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Kymera Therapeutics (KYMR) stake by 40% in Q1 2026, buying an estimated $845K and bringing the position to 37,185 shares worth $3.1M. The position accounts for 0.01% of the portfolio, ranked #1186.

State of Wisconsin Investment Board first reported a position in KYMR in Q1 2021 and has held it in 21 quarters since. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • State of Wisconsin Investment Board held 37,185 shares of Kymera Therapeutics worth $3.1M as of Q1 2026.
  • State of Wisconsin Investment Board bought 10,672 Kymera Therapeutics shares in Q1 2026, an estimated $845K.
  • Kymera Therapeutics made up 0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1186 holding.
  • State of Wisconsin Investment Board first reported a position in Kymera Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.